Simon Neil Pimstone

Simon Neil Pimstone is a declared insider of Xenon Pharmaceuticals Inc., with filings sourced from SEC (Form 4). Between 29 July 2016 and 1 June 2023, the trades on record add up to 43 filings.

In open-market terms, that means 1 purchase worth €12k on one side and 20 sales worth €10.2M on the other. On balance, insiders were net sellers of €10.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 13 option exercises. In 2023 alone, the filings show no purchases and 10 sales.

The latest filing, published on 2 June 2023, reports a transaction of €612k in Xenon Pharmaceuticals Inc. The clock since the last published purchase (14 August 2017) now reads 3,375 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.